Korea’s IMM plots final close on $1.8bn by year-end

IMM RoseGold IV is already about one-third deployed across four investments, including the $500m carve-out of Genuone Sciences.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this